Arcus Biosciences
RCUS
Operating Margin for Arcus Biosciences (RCUS)
Operating Margin as of April 2024 (TTM): -236.36%
According to Arcus Biosciences 's latest financial reports and stock price the company's current Operating Margin is -236.36%. At the end of 2021 the company had an Operating Margin of 14.27%.
Operating Margin history for Arcus Biosciences from 2018 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | 14.27% | -109% |
| 2020 | -158.49% | -71.94% |
| 2019 | -564.73% | -4.88% |
| 2018 | -593.73% | -84.2% |
| 2017 | -3,756.69% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.